Daniel Vitt

Daniel Vitt serves as Chief Executive Officer at Immunic Therapeutics. Immunic Therapeutics operates in the research sector with approximately 84.0 employees. The company is headquartered in Munich, Bavaria. Immunic Therapeutics generates annual revenue of 37500000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 1,671 executive contacts are available in Bavaria.
• • Our database includes 201,469 c suite-level executives.

Outlook Apache Mobile Friendly Etracker WordPress.org Piwik Basis Data Analytics

healthcare biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research immunology oral therapies chronic inflammatory diseases autoimmune diseases vidofludimus calcium imu-856 imu-381 clinical trials multiple sclerosis celiac disease ulcerative colitis therapeutic efficacy safety & tolerability small molecule modulators neuroprotective effects dihydroorotate dehydrogenase dhodh inhibition sirtuin 6 sirt6 gastrointestinal diseases intestinal barrier function regeneration of bowel epithelium immune response clinical development phase 3 trials phase 2 trials first-in-class weight management patient needs therapeutic options chronic conditions pharmaceutical industry biopharmaceuticals research & development dosage forms patient-friendly health outcomes innovation drug development clinical data medical research therapeutics biotech solutions transformative healthcare chronic disease management patient care strategies safety profiles medical therapies health technology health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Daniel Vitt in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Immunic Therapeutics.

Daniel Vitt's Position in the MessageCEO Database

• •Daniel Vitt is 1 of 1 verified executive contact we track at Immunic Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •1,664 verified executive contacts in Bavaria are in the database.
• •13 verified contacts work at research companies in the 84.0 employee range (same size as Immunic Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Daniel Vitt directly?

Daniel Vitt's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Immunic Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Daniel Vitt work for?

Daniel Vitt is Chief Executive Officer at Immunic Therapeutics, a company in the research sector with 84.0 employees. The company is based in Munich, Bavaria.

Can I pitch or sell to Daniel Vitt?

As Chief Executive Officer at Immunic Therapeutics, Daniel Vitt is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Daniel Vitt directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Daniel Vitt in?

Daniel Vitt works in the research industry as Chief Executive Officer at Immunic Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Daniel Vitt's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Daniel Vitt's profile is kept up-to-date with the latest available information.

Last updated: July 22, 2026